SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 379.91+0.4%Nov 11 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: arun gera who wrote (176364)8/15/2021 5:06:33 AM
From: TobagoJack  Read Replies (2) of 217688
 
Possibly good news on the vaxx front, in any case could be in the right direction …

I wonder what Sinovac knows that the CIA, to make itself useful, should find out - what is the point of anti-delta shot if the current crop of vaccines used in infested domains are working?

bloomberg.com

Sinovac to Seek Approval to Test Anti-Delta Shot (11:29 a.m. HK)

Beijing-based Sinovac, manufacturer of an inactivated Covid-19 vaccine, will seek approval to do further testing on a shot specifically targeting the delta variant of the coronavirus before October this year, state-backed Global Times reported Sunday, citing the company’s general manager Gao Qiang in a recent interview.

Two shots of Sinovac’s current vaccine that has been widely used in China and across much of the developing world can “remarkably” reduce the risks of developing symptoms and critical illness from infection by the delta variant, Gao was cited as saying by the Global Times.

Gao added that the results of real-world research on using the Sinovac vaccine as a booster shot, following full immunization, conducted in China, Turkey, Chile and other countries, will be obtained soon.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext